Skip to content
Life Sciences

AI search visibility for life sciences

Clinicians, patients, partners and buyers ask AI about treatments, suppliers and research partners. In life sciences, engines lean on regulators and publications, and accuracy is non-negotiable.

The engines life sciences customers now ask
  • ChatGPT
  • Claude
  • Perplexity
  • Gemini
  • Google AI Overviews
What changed

Life Sciences marketing, before and after AI answers

The SEO era

Life sciences companies relied on medical affairs, conferences, publications and regulated product sites.

The AI answer

AI answers draw heavily on regulators, peer-reviewed literature and authoritative databases. Companies are named when their approvals, data and capabilities are published clearly, and described inaccurately when they are not.

Challenges

What makes life sciences hard to win in AI answers

Regulation constrains claims

Promotional rules limit what companies can say directly.

Authoritative sources dominate

Regulators, journals and databases outrank company pages.

Inaccuracy carries real risk

Wrong indications or approvals in AI answers matter.

Recommended playbook

The playbook for life sciences businesses

  1. 01

    Publish approvals and indications accurately

    Matched with regulatory databases.

  2. 02

    Make capabilities readable

    For CROs and suppliers, services and experience in text.

  3. 03

    Support publication and data access

    Engines rely on literature.

  4. 04

    Monitor AI accuracy

    Check what engines say about products and correct sources.

  5. 05

    Answer partner questions

    Licensing, partnering and supply clearly.

AI search for life sciences: questions

Do AI engines describe pharmaceutical products?

Yes, mostly from regulators and literature. Accurate, consistent company information reduces errors.

Do B2B buyers in life sciences use AI?

Yes, to shortlist CROs, suppliers and partners by capability.

What is the main risk in AI answers for life sciences?

Inaccurate descriptions of approvals, indications or safety, which is why monitoring matters.

Want more qualified enquiries in life sciences?

Start with a free, capped snapshot of one buyer journey: the questions your customers ask, who gets named, and where enquiries leak. If the economics hold, we scope a programme.